MEDTECH SHOWCASE
NC Biotechnology Center April 29, 2025
6 to 9 PM
Schedule of Events
6:00 - 6:15 PM
6:15 - 6:35 PM
6:35 - 6:55 PM
6:55 - 7:15 PM
7:15 - 7:35 PM
7:35 - 7:45 PM
7:45 - 8:45 PM
8:45 - 9:00 PM
Special Thanks
Welcome Wound CAARE
NG-ineered Medical NeoMate EntryWave Access Break
Demo Session / Voting Awards
The Class of 2025 would like to thank their clinical mentors, guest speakers, and collaborators!
The faculty would like to thank Laura Schranz, BME Director of Development, and Yvette Thompson, BME Program Specialist, for making this Showcase a reality!!
John Hayes Matt Penny Arun Mohan
MedTech Faculty
Nick Jardine
David Zaharoff
Guest Judges
Amy DeWinter
Ms. DeWinter is the Founder of Ascenda Medical Marketing which provides medical marketing and project management services to established and earlystage medtech companies. With over 25 years of experience, she has a strong background in emerging technologies, particularly in minimally invasive surgical platforms, and has been integral in several product launches and business development ventures. After taking on roles with increasing responsibilities at TherOx, Edwards Life Sciences and Teleflex, Ms. DeWinter began her own consulting and contract work in 2008 and launched Ascenda in 2012 where she assists multiple organizations in everything from product naming to clinician training programs and market planning.
Charles Harr, MD, MBA, FACHE
Dr. Harr is Chief Medical Officer and a cardiothoracic surgeon at WakeMed. As an executive, his focus is on optimizing organizational performance, delivering leading-edge care, and generating exceptional, cost-effective results. As a surgeon, he is a leader in minimally invasive robotic surgery with the #2 ranked program in volume in the Mid-Atlantic region. Dr. Harr is also a retired rear admiral of the United States Navy with more than 24 years of service to this country including numerous thoracic, vascular and trauma surgeries for soldiers both on and off the battlefield. Dr. Harr is the recipient of the Legion of Merit award, the Navy/Marine Corps Commendation Medal and the National Defense Service Medal.
Allison London Brown
Ms. London Brown is a serial entrepreneur with 20+ years of experience in medical devices, diagnostics, and pharmaceuticals with a passion for women’s health. As an executive with Johnson & Johnson, GE Healthcare and Stanley Healthcare Solutions, she helped launch more than 90 products. Ms. London Brown was CEO/Co-Founder of UVision360, the developer of the LUMINELLE®, a fully integrated hysteroscopy system, which she led to a successful acquisition by Caldera Medical in 2024. She currently serves as a Board Member for Plakous Therapeutics, a fractional Commercial Strategist for Galaxy Diagnostics and other start-ups in the area. She is the author of three publications, co-inventor of 11 issued patents, and speaker at various programs for Women in STEM, Leadership and Strategy.
Ryan D'Amore rpdamore@ncsu.edu
Wound CAARE is developing Seal Safe, a novel drape technology designed to enhance the reliability of Negative Pressure Wound Therapy (NPWT). Seal Safe uses color-changing pigment to provide patients and clinicians with a clear, immediate visual indication of leaks, making it easier to identify and patch problem areas. In its uniform, transparent state, Seal Safe also confirms proper adherence of the drape to the skin. Since clinicians report that leaks occur in nearly every NPWT patient, Seal Safe aims to save time, reduce costs, and improve outcomes by streamlining leak detection and maintenance for both patients and providers. Connect with us on LinkedIn!
Angel Koshy aakoshy@ncsu.edu
Alex Martjuchin apmartju@ncsu.edu
Carson Palmer cepalmer@ncsu.edu
At NeoMate, we’re redefining neonatal care by minimizing invasiveness and enhancing nursing efficiency in glucose monitoring. Our novel innovation is a non-invasive glucose monitor that leverages near-infrared (NIR) light to detect glucose levels by analyzing the light not absorbed by glucose molecules. Designed for continuous use, our device delivers up to 6 hours of real-time data, reducing nurse workload by 50% and ensuring reliable measurements, even during shift transitions. By eliminating the need for up to 8 painful heel pricks each day, NeoMate provides a gentle, more efficient alternative for both neonates and their care teams.
Michael Cotton mjcotto2@ncsu.edu
Keely Murphy kgmurph2@ncsu.edu
Connect with us on LinkedIn!
Rayna Patel rpatel36@ncsu.edu
Kateland Wilhite kiwilhit@ncsu.edu
EntryWave Access is designing a compact cordless laparoscopic trocar and obturator system to benefit procedures within the field of minimally invasive surgery. Our product, the Marlin System, eliminates the need for a laparoscope upon initial entry into the abdomen while still allowing for direct visualization during port placements. The obturator is bladed to reduce the effort required to insert the trocar through the tougher layers of the abdominal wall and includes enhanced ergonomics, unlike other optical trocar systems currently on the market. We are currently seeking clinical and industry contacts from leaders in the field.
